Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.

ClinicalTrials.gov ID: NCT00002126

Public ClinicalTrials.gov record NCT00002126. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 1, 2026, 6:04 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To determine, in HIV-infected patients, the efficacy of filgrastim ( recombinant-methionyl human granulocyte-colony stimulating factor; G-CSF ) in preventing grade 4 neutropenia, i.e., absolute neutrophil count (ANC) \< 500 cells/mm3.

Study identification

NCT ID
NCT00002126
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Amgen
Industry
Enrollment
250 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 24, 2005

United States locations

U.S. sites
16
U.S. states
15
U.S. cities
16
Facility City State ZIP Site status
Univ of Alabama at Birmingham / AIDS Outpatient Clinic Birmingham Alabama 35294 —
Maricopa County Med Ctr Phoenix Arizona 85008 —
CARE Ctr / UCLA Med Ctr Los Angeles California 90095 —
UCSF - San Francisco Gen Hosp San Francisco California 94110 —
Univ Hosp / Univ of Colorado Health Sci Ctr Denver Colorado 80262 —
George Washington Univ Med Ctr Washington D.C. District of Columbia 20037 —
TheraFirst Med Ctrs Inc Fort Lauderdale Florida 33308 —
Rush Presbyterian - Saint Luke's Med Ctr Chicago Illinois 60612 —
Univ of Kansas School of Medicine Wichita Kansas 672143124 —
Tulane Univ Med School New Orleans Louisiana 701122699 —
New England Deaconess Hosp Boston Massachusetts 02215 —
SUNY / Health Sciences Ctr at Stony Brook Stony Brook New York 11794 —
Nalle Clinic Charlotte North Carolina 28207 —
Univ Hosp of Cleveland / Case Western Reserve Univ Cleveland Ohio 44106 —
Kaiser Permanente Med Ctr Portland Oregon 97227 —
Univ TX San Antonio Health Science Ctr San Antonio Texas 78284 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002126, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2005 · Synced Nov 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00002126 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →